Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Glia in Health & Disease
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Cuprizone neurotoxicity in the rat: morphologic observations.
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Keystone Symposium: Viral Immunity
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
American Academy of Neurology Annual Meeting
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
Episode 32 with Dr. David Holtzman on the connection between MS and Alzheimer 's disease
Episode 29 with Dr. Monica Carson on MS research funding
Immunology 2015
MS Frontiers 2015
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Biogen Idec's TECFIDERA™ (dimethyl fumarate) approved in US as a first-line oral treatment for multiple sclerosis

Pages